University researchers make up to $110K from industry per year; Gardasil approved for two new uses;

> Researchers working at U.S. universities are getting a nice boost from industry--an average of $33,000 a year--with some earning as much as $110,869, according to a new survey. FierceBiotechResearch

> Merck's Gardasil--which fights HPV infections--has been approved for two indications, a good thing for the drugmaker, given that a potential competitor seems closer to entering the market. FiercePharma

> As if they weren't up to their necks in contentious issues already, of late legislators have been struggling with debates over why various areas of the country differ so radically in how they spend Medicare dollars. FierceHealthFinance

> On a happier Medicare note, it appears that most medical practices are still accepting the federal health plan's beneficiaries despite their concerns over payment levels. FierceHealthFinance

And Finally... Unlike this man, no matter how sorry I might feel about stuff, I maintain a strict "no scorpions in my life" policy. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.